Thermo Fisher Scientific (NY:TMO)

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy ↗

March 21, 2025

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today ↗

March 19, 2025

Via Benzinga

Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis

March 18, 2025

$100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today ↗

Thermo Fisher Scientific Unusual Options Activity ↗

February 21, 2025

Via Benzinga

Looking Into Thermo Fisher Scientific's Recent Short Interest ↗

February 20, 2025

Via Benzinga

March 14, 2025

Via Benzinga

Is the Market Bullish or Bearish on Thermo Fisher Scientific? ↗

March 14, 2025

Via Benzinga

3 Reasons to Sell TMO and 1 Stock to Buy Instead

March 14, 2025

Over the last six months, Thermo Fisher shares have sunk to $508.90, producing a disappointing 17.1% loss - worse than the S&P 500’s 1.2% drop. This might have investors contemplating their next move.

These 20 blue chip companies are the largest traded on U.S. exchanges.

Topics Stocks

Market Whales and Their Recent Bets on TMO Options ↗

March 13, 2025

Via Benzinga

On Sale Now: 20 Blue Chip Stocks to Buy ↗

March 13, 2025

Via The Motley Fool

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

February 03, 2025

Via Benzinga

Analyst Expectations For Thermo Fisher Scientific's Future ↗

January 31, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 11, 2025

Via Benzinga

3 Dividend Stocks That Recently Raised Payouts More Than 10% ↗

March 06, 2025

Via The Motley Fool

Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom' ↗

March 06, 2025

David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs (NYSE: GS), has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends.

Via Benzinga

Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

March 05, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers.

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Topics Economy

March 03, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSE:RVTY) and the best and worst...

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

Topics Economy

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

February 26, 2025

From Trian Fund Management, L.P.

Via GlobeNewswire

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion ↗

February 25, 2025

Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.

Via Benzinga

Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business

February 25, 2025

Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025

February 24, 2025

Thermo Fisher Scientific Increases Quarterly Dividend

February 19, 2025

Thermo Fisher Scientific Elects New Director to Board

February 19, 2025

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years ↗

February 18, 2025

Via Benzinga

3 Healthcare Stocks Skating on Thin Ice

February 12, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Topics Stocks

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 10, 2025

Via Chartmill

Gapping S&P500 stocks in Monday's session ↗

February 10, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO

February 04, 2025